CAPTRUST Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Sell |
160,641
-28,101
| -15% | -$1.94M | 0.02% | 440 |
|
|
2025
Q1 | $13.1M | Buy |
188,742
+52,156
| +38% | +$3.62M | 0.03% | 366 |
|
|
2024
Q4 | $11.7M | Sell |
136,586
-18,626
| -12% | -$1.6M | 0.03% | 337 |
|
|
2024
Q3 | $18.5M | Sell |
155,212
-5,611
| -3% | -$668K | 0.05% | 256 |
|
|
2024
Q2 | $23M | Buy |
160,823
+10,997
| +7% | +$1.57M | 0.07% | 197 |
|
|
2024
Q1 | $19.2M | Buy |
149,826
+4,947
| +3% | +$635K | 0.07% | 228 |
|
|
2023
Q4 | $15M | Buy |
144,879
+34,278
| +31% | +$3.55M | 0.05% | 286 |
|
|
2023
Q3 | $10.1M | Buy |
110,601
+28,361
| +34% | +$2.58M | 0.04% | 337 |
|
|
2023
Q2 | $6.65M | Buy |
82,240
+2,564
| +3% | +$207K | 0.03% | 416 |
|
|
2023
Q1 | $6.34M | Buy |
79,676
+8,740
| +12% | +$695K | 0.03% | 402 |
|
|
2022
Q4 | $4.8M | Buy |
70,936
+6,994
| +11% | +$473K | 0.02% | 442 |
|
|
2022
Q3 | $3.19M | Buy |
63,942
+14,374
| +29% | +$716K | 0.02% | 531 |
|
|
2022
Q2 | $2.76M | Buy |
49,568
+6,246
| +14% | +$348K | 0.02% | 521 |
|
|
2022
Q1 | $2.43M | Buy |
43,322
+5,858
| +16% | +$328K | 0.02% | 550 |
|
|
2021
Q4 | $2.1M | Buy |
37,464
+12,000
| +47% | +$672K | 0.01% | 554 |
|
|
2021
Q3 | $1.22M | Buy |
25,464
+274
| +1% | +$13.1K | 0.01% | 670 |
|
|
2021
Q2 | $1.06M | Buy |
25,190
+1,532
| +6% | +$64.2K | 0.01% | 701 |
|
|
2021
Q1 | $808K | Buy |
23,658
+1,628
| +7% | +$55.6K | 0.01% | 778 |
|
|
2020
Q4 | $769K | Sell |
22,030
-4,300
| -16% | -$150K | 0.01% | 690 |
|
|
2020
Q3 | $912K | Buy |
26,330
+3,126
| +13% | +$108K | 0.02% | 539 |
|
|
2020
Q2 | $762K | Buy |
23,204
+5,912
| +34% | +$194K | 0.01% | 575 |
|
|
2020
Q1 | $523K | Buy |
17,292
+266
| +2% | +$8.05K | 0.01% | 582 |
|
|
2019
Q4 | $497K | Buy |
+17,026
| New | +$497K | 0.01% | 688 |
|